API
< Back to all clusters
[HEALTH] · Spain · 2 sources

started · updated

IBBTEC researchers develop iron contrast to detect and slow cardiac fibrosis

Researchers from the FIBROHEART group at the Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) have demonstrated that a new iron-based contrast agent for magnetic resonance imaging (MRI) can detect cardiac fibrosis and reduce its progression. The study was conducted using laboratory-engineered human cardiac tissue.

Led by Aitziber L. Cortajarena from the CIC biomaGUNE research center and biomedical lead Ana V. Villar from the University of Cantabria, the research offers a potential alternative to gadolinium, the metal currently used in most contrast MRIs.

Cardiac fibrosis occurs when fibroblasts produce excessive collagen following heart damage, such as from a heart attack or hypertension. This accumulation makes the heart rigid, leading to heart failure. Currently, there are no approved treatments specifically designed to halt this process. The study, published in Advanced Functional Materials, utilized 3D tissue engineering to replicate fibrotic areas using patient-derived fibroblasts.

Entities

Ana V. Villar · CIC biomaGUNE · FIBROHEART · IBBTEC · University of Cantabria